Dr. আকাশ শুক্লা

Dr. Akash Shukla is a highly esteemed Hepatologist and Gastroenterologist with over two decades of clinical experience. He holds an MBBS, MD in Medicine, and DM in Gastroenterology. Further enhancing his expertise, Dr. Shukla has completed fellowships in Hepatology and Liver Transplantation from renowned institutions in Barcelona, Spain, and Pittsburgh, USA.

তাঁর বর্ণাঢ্য কর্মজীবন জুড়ে, Dr. Shukla has been at the forefront of treating complex liver diseases, including Hepatocellular Carcinoma, Hepatitis B and C, Cirrhosis, and Hepatic Encephalopathy. His proficiency extends to performing liver transplantations and addressing pediatric gastroenterological conditions.

তার ক্লিনিক্যাল প্র্যাকটিস ছাড়াও, Dr. Shukla is a dedicated academician with over 86 original research papers to his credit. He has been instrumental in teaching and training gastroenterologists and hepatologists for the past 15 years. His research contributions have been recognized internationally, earning him the Plenary Award at the Asia-Pacific Association for the Study of Liver (APASL) in 2018, the Best Research Paper Award at the VALDIG meeting in Switzerland in 2016, and four national awards.

• এমবিবিএস
• এমডি (মেডিসিন)
• ডিএম (গ্যাস্ট্রোএন্টারোলজি)

• লিভার ডিজিজ
• হেপাটোসেলুলার কার্সিনোমা
• হেপাটাইটিস বি এবং সি
• যকৃতের পচন রোগ
• হেপাটিক এঞ্চেফালপাথ্য
• আঠালো কোলাইটিস
• Acidity and related gastrointestinal disorders

• লিভার ট্রান্সপ্লান্ট
• ন্যূনতম আক্রমণাত্মক লিভার সার্জারি
• ন্যূনতম আক্রমণাত্মক অগ্ন্যাশয় সার্জারি
• অগ্ন্যাশয় প্রতিস্থাপন
• হুইপলস সার্জারি
• লিভারের রোগ ব্যবস্থাপনা
• Treatment of Hepatocellular Carcinoma
• ব্যাপক গ্যাস্ট্রোএন্টারোলজি পরিষেবা
• পেডিয়াট্রিক গ্যাস্ট্রোএন্টারোলজি

• EASL-VALDIG Steering Committee: Selected as the first ever non-European medical specialist to be nominated to the Steering Committee of the Vascular Liver Diseases Interest Group, European Association for the Study of the Liver.
• Baveno VII Panel Member: Appointed international consensus panel expert standardizing global definitions for portal hypertension.
• INASL Governing Council: Elected Member of the Governing Council of the Indian National Association for the Study of the Liver.
• National Viral Hepatitis Control Program (NVHCP): Appointed Technical Resource Group (TRG) Member under the Government of India.

• EASL-VALDIG Best Research Paper Award (Switzerland - 2016): Conferred internationally by the Vascular Liver Disease Interest Group (VALDIG) of the European Association for the Study of the Liver (EASL) for breakthrough clinical research tracking vascular liver defects.
• APASL Plenary Award (2018): Bestowed globally by the Asian Pacific Association for the Study of the Liver (APASL) during their annual congress for outstanding, paradigm-shifting scientific presentations in advanced hepatology.
• Four-Time National Research Award Winner: Conferred across prominent central Indian medical bodies for authoring and presenting elite, peer-reviewed clinical research on portal hypertension and cirrhosis.